Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Certara2026 年 6 月 26 日

Poster

将内源性配体竞争纳入治疗性单克隆抗体的机制全身 PBPK 模型

Discover how endogenous ligand competition was incorporated into a whole-body PBPK model to improve prediction…

Certara2026 年 6 月 23 日

Poster

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Learn how Certara's IO Simulator was used to predict efficacy, cytokine release syndrome risk, and…

Certara2026 年 6 月 23 日

Poster

Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab

Discover how Quantitative Systems Pharmacology (QSP) was used to predict cytokine release syndrome risk and…

Certara2026 年 6 月 23 日

Poster

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling

Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…

Certara2026 年 6 月 22 日

Poster

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…

Certara2026 年 6 月 22 日

Poster

Machine Learning based drug renal clearance predictor development and application

A machine learning QSAR model predicts human renal clearance from simple, easy-to-obtain inputs and sharpens…

Certara2026 年 6 月 22 日

Poster

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Discover how active learning and Bayesian optimization improve virtual population generation for quantitative systems pharmacology…

Certara2026 年 6 月 18 日

Poster

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Discover how a mechanistic quantitative systems pharmacology (QSP) model predicts mast cell inhibition and depletion…

Certara2026 年 6 月 16 日

Blog

Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM

A recap of the Certainty 2026 Discovery UGM in Boston, covering the top themes from…

Certara2026 年 6 月 15 日

模型引导的药物开发

Enhancing clinical trials with real-world evidence in pregnancy research

将内源性配体竞争纳入治疗性单克隆抗体的机制全身 PBPK 模型

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

Machine Learning based drug renal clearance predictor development and application

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Data, Models, and Modalities: Key Themes from the Certainty 2026 Discovery UGM

订阅时事通讯

快捷链接

解决方案

联系我们